Royal Bank of Canada restated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $8.00 price objective on the stock, down from their previous price objective of $10.00. PYXS has been the topic of a number of other […]

Royal Bank of Canada restated their outperform rating on shares of Petco Health and Wellness (NASDAQ:WOOF – Free Report) in a research report sent to investors on Friday,Benzinga reports. The firm currently has a $6.00 price target on the stock. A number of other analysts have also commented on WOOF. Wedbush raised their price target […]